Feasibility of Using NeoSpot at Community Settings

CompletedOBSERVATIONAL

Enrollment

149

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions

Pregnancy Related

Interventions

DEVICE

NeoSpot

Pregnant women will undergo screening of their vital signs using the NeoSpot device.

Trial Locations (1)

Kanyama First Level Hospital, Lusaka

All Listed Sponsors

collaborator

Neopenda, PBC

INDUSTRY

collaborator

Wellcome Trust

OTHER

lead

Centre for Infectious Disease Research in Zambia

OTHER